ARIETTA 65 IntuitiveFusion - Overview

The “One-Cart-Solution” for Urology comes with the new intuitive integrated software for MRI-US fusion prostate biopsy.

Prostate cancer (PCa) is one of the most commonly diagnosed cancer in men, with an estimated 1.4 million diagnoses worldwide in 2020^*1. Prostate Biopsy is the unique method to confirm PCa. 

Following the latest European Guidelines^*2, MRI examination before prostate biopsy is strongly recommended for biopsy naïve patients and patients with prior negative biopsy.

MRI-US fusion prostate biopsy is expected to improve the cancer detection rate by fusing MRI images with real-time ultrasound images, even when it is difficult to confirm a suspected cancerous area on ultrasound images alone.

The ARIETTA 65 IntuitiveFusion is a compact system integrating BiopSee software^*3, which have advanced prostate fusion biopsy capabilities, into the ARIETTA 65 Diagnostic Ultrasound system for prostate cancer diagnosis to treatment support. It can be used not only in operating rooms where space is limited, but also in outpatient clinics, meeting the needs of a wide range of Urologists, from beginners to experts.

The ARIETTA 65 IntuitiveFusions provides fusion biopsy planning and navigation with intuitive fusion technology and workflow for both rigid and elastic fusion. Biopsy results are recorded as a data set and can be used for Focal Therapy and active surveillance.